 |
|
Screening for Cognitive Dysfunction in Multiple Sclerosis
Michael R. Basso, PhD;
Suzanne Beason-Hazen, MA;
Joanne Lynn, MD;
Kottil Rammohan, MD;
Robert A. Bornstein, PhD
Arch Neurol. 1996;53(10):980-984.
Abstract
| |
Background
With the use of comprehensive neuropsychological assessments, a substantial proportion of patients with multiple sclerosis have been found to have substantial cognitive impairment. Although data generated from comprehensive examinations are useful in making recommendations for treatment interventions and compensatory strategies, the cost of such assessments prohibits their use with all patients.
Objective
To develop a screening battery to detect cognitive impairment in patients with multiple sclerosis that is sensitive, specific, brief, and cost-effective, and could identify patients who might benefit from a more comprehensive neuropsychological examination.
Design
On the basis of a comprehensive neuropsychological assessment battery, the presence of significant cognitive impairment was determined in patients with multiple sclerosis. The screening battery consisted of a subset of tests from the comprehensive battery. Performance on the screening battery was then used to predict presence of cognitive impairment on the comprehensive battery in validation and crossvalidation samples. Severity of impairment on the screening battery was also regressed on ratings of functional impairment derived from the Expanded Disability Status Scale.
Results
In the validation sample, the screening battery had 100% sensitivity, 80% specificity, and 88.1% overall diagnostic accuracy. In the cross-validation sample, the screening battery had 100% sensitivity, 81.8% specificity, and an overall diagnostic accuracy rate of 90.7%. x2 tests showed that the accuracy of the screening battery was significantly better than chance in both samples. Performance on the screening battery also predicted the level of disability ratings on the Expanded Disability Status Scale and functional systems scales.
Conclusions
The screening battery had a high degree of sensitivity, specificity, and diagnostic accuracy, while maintaining a brief administration time and high cost-effectiveness. The screening battery also predicted higher levels of disability and functional impairment as assessed by the Expanded Disability Status Scale, thereby enhancing its clinical utility. Despite its advantages, the findings do not suggest that the screening battery may be an effective substitute for a more detailed examination.
Author Affiliations
From the Departments of Psychiatry (Drs Basso and Bornstein and Ms Beason-Hazen) and Neurology (Drs Lynn, Rammohan, and Bornstein), Ohio State University Medical Center, Columbus.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
The Faces Symbol Test, a newly developed screening instrument to assess cognitive decline related to multiple sclerosis: first results of the Berlin Multi-Centre FST Validation Study
Scherer et al.
Mult Scler 2007;13:402-411.
ABSTRACT
Screening for cognitive impairment in multiple sclerosis using the Symbol Digit Modalities Test
Parmenter et al.
Mult Scler 2007;13:52-57.
ABSTRACT
The unique impact of changes in normal appearing brain tissue on cognitive dysfunction in secondary progressive multiple sclerosis patients
Cox et al.
Mult Scler 2004;10:626-629.
ABSTRACT
Three screening batteries to detect cognitive impairment in multiple sclerosis
Aupperle et al.
Mult Scler 2002;8:382-389.
ABSTRACT
Comparison of two brief neuropsychological batteries in people with multiple sclerosis
Solari et al.
Mult Scler 2002;8:169-176.
ABSTRACT
Visuoperceptual impairment in MS patients: nature and possible neural origins
Vleugels et al.
Mult Scler 2001;7:389-401.
ABSTRACT
Multiple sclerosis, disease modifying treatments and depression: a critical methodological review
Feinstein
Mult Scler 2000;6:343-348.
ABSTRACT
Visuoperceptual impairment in multiple sclerosis patients diagnosed with neuropsychological tasks
Vleugels et al.
Mult Scler 2000;6:241-254.
ABSTRACT
Assessment of cognitive and psychological functions in patients with multiple sclerosis: considerations for databasing
Beatty
Mult Scler 1999;5:239-243.
ABSTRACT
Cognitive function in primary progressive and transitional progressive multiple sclerosis: A controlled study with MRI correlates
Camp et al.
Brain 1999;122:1341-1348.
ABSTRACT
| FULL TEXT
Neurophysiological and cognitive markers of disease evolution in multiple sclerosis
Comi et al.
Mult Scler 1998;4:260-265.
ABSTRACT
Multiple Sclerosis Screening Examinations
Beatty
Arch Neurol 1997;54:352-352.
ABSTRACT
|
